Relationship Between Six Insulin Resistance Surrogates and Nonalcoholic Fatty Liver Disease Among Older Adults: A Cross-Sectional Study

References

• Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70(3):531–544. doi:10.1016/j.jhep.2018.10.033
   PubMed Web of Science ®Google Scholar
• Palma R, Pronio A, Romeo M, et al. The role of insulin resistance in fueling NAFLD pathogenesis: from molecular mechanisms to clinical implications. J Clin Med. 2022;11(13):3649. doi:10.3390/jcm11133649
   PubMed Web of Science ®Google Scholar
• Zhang C-H, Zhou B-G, Sheng J-Q, Chen Y, Cao Y-Q, Chen C. Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies. Pharmacol Res. 2020;159. doi:10.1016/j.phrs.2020.104984
   Web of Science ®Google Scholar
• Muzurovic E, Mikhailidis DP, Mantzoros C. Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk. Metabolism. 2021;119:154770. doi:10.1016/j.metabol.2021.154770
   PubMed Web of Science ®Google Scholar
• Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904. doi:10.1016/j.jhep.2018.05.036
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhou F, Wang W, et al. Epidemiological Features of NAFLD From 1999 to 2018 in China. Hepatology. 2020;71(5):1851–1864. doi:10.1002/hep.31150
   PubMed Web of Science ®Google Scholar
• Zhou F, Zhou J, Wang W, et al. Unexpected rapid increase in the burden of NAFLD in China from 2008 to 2018: a systematic review and meta-analysis. Hepatology. 2019;70(4):1119–1133. doi:10.1002/hep.30702
   PubMed Web of Science ®Google Scholar
• Lee HW, Wong VW. Changing NAFLD epidemiology in China. Hepatology. 2019;70(4):1095–1098. doi:10.1002/hep.30848
   PubMed Web of Science ®Google Scholar
• Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World J Gastroenterol. 2014;20(27):9072–9089. doi:10.3748/wjg.v20.i27.9072
   PubMed Web of Science ®Google Scholar
• Nascimbeni F, Pais R, Bellentani S, et al. From NAFLD in clinical practice to answers from guidelines. J Hepatol. 2013;59(4):859–871. doi:10.1016/j.jhep.2013.05.044
   PubMed Web of Science ®Google Scholar
• Khan RS, Bril F, Cusi K, Newsome PN. Modulation of insulin resistance in nonalcoholic fatty liver disease. Hepatology. 2019;70(2):711–724. doi:10.1002/hep.30429
   PubMed Web of Science ®Google Scholar
• Otten J, Ahren B, Olsson T. Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis. Diabetologia. 2014;57(9):1781–1788. doi:10.1007/s00125-014-3285-x
   PubMed Web of Science ®Google Scholar
• Mirr M, Skrypnik D, Bogdanski P, Owecki M. Newly proposed insulin resistance indexes called TyG-NC and TyG-NHtR show efficacy in diagnosing the metabolic syndrome. J Endocrinol Invest. 2021;44(12):2831–2843. doi:10.1007/s40618-021-01608-2
   PubMed Web of Science ®Google Scholar
• Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
   PubMed Web of Science ®Google Scholar
• Lim J, Kim J, Koo SH, Kwon GC. Comparison of triglyceride glucose index, and related parameters to predict insulin resistance in Korean adults: an analysis of the 2007–2010 Korean National Health and Nutrition Examination Survey. PLoS One. 2019;14(3):e0212963. doi:10.1371/journal.pone.0212963
   PubMed Web of Science ®Google Scholar
• Anoop SS, Dasgupta R, Rebekah G, et al. Lipid accumulation product (LAP) as a potential index to predict risk of insulin resistance in young, non-obese Asian Indian males from Southern India: observations from hyperinsulinemic-euglycemic clamp studies. BMJ Open Diabetes Res Care. 2021;9(1):e002414. doi:10.1136/bmjdrc-2021-002414
   PubMed Web of Science ®Google Scholar
• Xia C, Li R, Zhang S, et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr. 2012;66(9):1035–1038. doi:10.1038/ejcn.2012.83
   PubMed Web of Science ®Google Scholar
• Jiang K, Luan H, Pu X, Wang M, Yin J, Gong R. Association between visceral adiposity index and insulin resistance: a cross-sectional study based on US adults. Front Endocrinol. 2022;13:921067. doi:10.3389/fendo.2022.921067
   PubMed Web of Science ®Google Scholar
• Liu Z, He H, Dai Y, et al. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. Lipids Health Dis. 2022;21(1):55. doi:10.1186/s12944-022-01661-7
   PubMed Web of Science ®Google Scholar
• Lee YC, Lee JW, Kwon YJ. Comparison of the triglyceride glucose (TyG) index, triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio, and metabolic score for insulin resistance (METS-IR) associated with periodontitis in Korean adults. Ther Adv Chronic Dis. 2022;13:20406223221122671. doi:10.1177/20406223221122671
   Web of Science ®Google Scholar
• Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533–544. doi:10.1530/EJE-17-0883
   PubMed Web of Science ®Google Scholar
• Song S, Son DH, Baik SJ, Cho WJ, Lee YJ. Triglyceride glucose-waist circumference (TyG-WC) is a reliable marker to predict non-alcoholic fatty liver disease. Biomedicines. 2022;10(9):2251. doi:10.3390/biomedicines10092251
   PubMed Web of Science ®Google Scholar
• Lu S, Kuang M, Yue J, Hu C, Sheng G, Zou Y. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population. Lipids Health Dis. 2022;21(1):95. doi:10.1186/s12944-022-01712-z
   PubMed Web of Science ®Google Scholar
• Li Q, Wang L, Wu J, Wang J, Wang Y, Zeng X. Role of age, gender and ethnicity in the association between visceral adiposity index and non-alcoholic fatty liver disease among US adults (NHANES 2003–2018): cross-sectional study. BMJ Open. 2022;12(3):e058517. doi:10.1136/bmjopen-2021-058517
   PubMed Web of Science ®Google Scholar
• Lee JH, Park K, Lee HS, Park HK, Han JH, Ahn SB. The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults. Clin Mol Hepatol. 2022;28(4):814–826. doi:10.3350/cmh.2022.0099
   PubMed Web of Science ®Google Scholar
• Sheng G, Lu S, Xie Q, Peng N, Kuang M, Zou Y. The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease. Lipids Health Dis. 2021;20(1):134. doi:10.1186/s12944-021-01561-2
   PubMed Web of Science ®Google Scholar
• Jennison E, Patel J, Scorletti E, Byrne CD. Diagnosis and management of non-alcoholic fatty liver disease. Postgrad Med J. 2019;95(1124):314–322. doi:10.1136/postgradmedj-2018-136316
   PubMed Web of Science ®Google Scholar
• Kahl S, Strassburger K, Nowotny B, et al. Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance. PLoS One. 2014;9(4):e94059. doi:10.1371/journal.pone.0094059
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503–508. doi:10.1016/j.dld.2009.08.002
   PubMedGoogle Scholar
• Cai X, Gao J, Hu J, et al. Dose-response associations of metabolic score for insulin resistance index with nonalcoholic fatty liver disease among a nonobese Chinese population: retrospective evidence from a population-based cohort study. Dis Markers. 2022;2022:4930355. doi:10.1155/2022/4930355
   PubMed Web of Science ®Google Scholar
• Ismaiel A, Jaaouani A, Leucuta D-C, Popa S-L, Dumitrascu DL. The visceral adiposity index in non-alcoholic fatty liver disease and liver fibrosis—systematic review and meta-analysis. Biomedicines. 2021;9(12):1890. doi:10.3390/biomedicines9121890
   PubMed Web of Science ®Google Scholar
• Xu C, Ma Z, Wang Y, et al. Visceral adiposity index as a predictor of NAFLD: a prospective study with 4-year follow-up. Liver Int. 2018;38(12):2294–2300. doi:10.1111/liv.13941
   PubMed Web of Science ®Google Scholar
• Wang R, Dai L, Zhong Y, Xie G. Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population. Lipids Health Dis. 2021;20(1). doi:10.1186/s12944-021-01506-9
   Web of Science ®Google Scholar
• Hu H, Han Y, Cao C, He Y. The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population. J Transl Med. 2022;20(1). doi:10.1186/s12967-022-03611-4
   Web of Science ®Google Scholar
• Huang J-F, Tsai P-C, Yeh M-L, et al. Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis. J Formos Med Assoc. 2020;119(1):89–96. doi:10.1016/j.jfma.2019.03.014
   PubMed Web of Science ®Google Scholar
• Sookoian S, Pirola CJ. Systematic review with meta-analysis: risk factors for non-alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients. Aliment Pharmacol Ther. 2017;46(2):85–95. doi:10.1111/apt.14112
   PubMed Web of Science ®Google Scholar
• Wang J, Su Z, Feng Y, Xi R, Liu J, Wang P. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. BMC Gastroenterol. 2021;21(1):482. doi:10.1186/s12876-021-02072-1
   PubMed Web of Science ®Google Scholar
• Yang S, Zhong J, Ye M, et al. Association between the non-HDL-cholesterol to HDL-cholesterol ratio and non-alcoholic fatty liver disease in Chinese children and adolescents: a large single-center cross-sectional study. Lipids Health Dis. 2020;19(1):242. doi:10.1186/s12944-020-01421-5
   PubMed Web of Science ®Google Scholar
• Heeren J, Scheja L. Metabolic-associated fatty liver disease and lipoprotein metabolism. Mol Metab. 2021;50:101238. doi:10.1016/j.molmet.2021.101238
   PubMed Web of Science ®Google Scholar
• Bril F, Barb D, Portillo‐Sanchez P, et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology. 2017;65(4):1132–1144. doi:10.1002/hep.28985
   PubMed Web of Science ®Google Scholar
• Engin A. Non-Alcoholic Fatty Liver Disease. Adv Exp Med Biol. 2017;960:443–467. doi:10.1007/978-3-319-48382-5_19
   PubMed Web of Science ®Google Scholar